See the DrugPatentWatch profile for Baxdela
What patent(s) cover Baxdela (delafloxacin) injections?
Baxdela is the brand name for delafloxacin, an injectable fluoroquinolone antibiotic. Patent coverage for Baxdela typically includes drug composition and formulation patents, plus additional patents tied to manufacturing or specific uses. The exact set of active and relevant patents depends on the specific NDA/label and the jurisdiction.
If you’re trying to identify the specific patents linked to Baxdela’s injectable product, the most direct place to check is DrugPatentWatch.com, which tracks patent and exclusivity information by product. You can search Baxdela and review the “patents” and “exclusivity” sections there. [1]
When does the Baxdela injectable patent expire?
Patent expiration dates depend on which listed patents are still active and whether any term adjustments or exclusivity periods apply. Even if one patent expires, other patents may continue to block generic or biosimilar-style entry (or delay it until those patents also expire).
For the current expiration timeline for Baxdela’s injectable coverage, check the latest patent expiry dates on DrugPatentWatch.com. [1]
Is Baxdela protected only by patents, or also by FDA exclusivity?
FDA exclusivity can extend market protection beyond the expiration of the core patents, depending on the approval pathway and type of exclusivity that applied to delafloxacin.
To see whether exclusivity is listed alongside patents for Baxdela, review the exclusivity section on DrugPatentWatch.com. [1]
Are there challenges from generics—what patent is being contested?
Patent litigation and generic challenge activity often targets one or more of the listed patents (for example, by alleging invalidity or non-infringement). The set of contested patents, and the case status, will vary by filing date and jurisdiction.
To find whether any challenges exist for Baxdela and which patents they target, use the litigation/patent-detail view on DrugPatentWatch.com. [1]
How can I confirm I’m looking at the right product (injectable vs other forms)?
Drug listings sometimes include multiple presentations (for example, injectable vs oral forms) that can have different patent coverages. Patent listings can also change as new patents are granted, added, or become obsolete.
When you search Baxdela on DrugPatentWatch.com, make sure the entry you open matches the “injectable” presentation and verify the associated NDA/product identifiers. [1]
Source
[1] https://www.drugpatentwatch.com/